BeiGene, Ltd. Quarterly Entity Common Stock, Shares Outstanding from Q1 2016 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BeiGene, Ltd. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2016 to Q3 2024.
  • BeiGene, Ltd. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 1.39B shares, a 1.95% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.39B +26.5M +1.95% Nov 1, 2024 10-Q 2024-11-12
Q2 2024 1.38B +3.26M +0.24% Aug 2, 2024 10-Q 2024-08-07
Q1 2024 1.36B -3.13M -0.23% May 3, 2024 10-Q 2024-05-08
Q4 2023 1.36B +3.37M +0.25% Feb 14, 2024 10-K/A 2025-01-08
Q3 2023 1.36B +9.86M +0.73% Nov 1, 2023 10-Q 2023-11-09
Q2 2023 1.38B +26.6M +1.97% Jul 31, 2023 10-Q 2023-08-02
Q1 2023 1.36B +21.3M +1.59% Apr 28, 2023 10-Q 2023-05-04
Q4 2022 1.36B +21.3M +1.6% Feb 14, 2023 10-K 2023-02-27
Q3 2022 1.35B +130M +10.7% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 1.35B +139M +11.4% Jul 31, 2022 10-Q 2022-08-08
Q1 2022 1.34B +144M +12% Apr 30, 2022 10-Q 2022-05-09
Q4 2021 1.33B +144M +12.1% Feb 14, 2022 10-K 2022-02-28
Q3 2021 1.22B +36.8M +3.11% Oct 31, 2021 10-Q 2021-11-04
Q2 2021 1.21B +34.7M +2.95% Jul 31, 2021 10-Q 2021-08-05
Q1 2021 1.2B +189M +18.8% Apr 30, 2021 10-Q 2021-05-06
Q4 2020 1.19B +183M +18.1% Feb 12, 2021 10-K 2021-02-25
Q3 2020 1.18B +395M +50.1% Oct 31, 2020 10-Q 2020-11-05
Q2 2020 1.18B +392M +50% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 1.01B +231M +29.6% Apr 30, 2020 10-Q 2020-05-11
Q4 2019 1.01B Feb 14, 2020 10-K 2020-03-02
Q3 2019 788M +16M +2.07% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 784M +17.3M +2.25% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 778M +78.8M +11.3% Apr 30, 2019 10-Q 2019-05-09
Q3 2018 772M +181M +30.7% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 767M +247M +47.5% Aug 8, 2018 10-Q 2018-08-09
Q1 2018 699M +180M +34.8% May 4, 2018 10-Q 2018-05-09
Q3 2017 591M +162M +37.6% Nov 8, 2017 10-Q 2017-11-13
Q2 2017 520M +92.3M +21.6% Aug 4, 2017 10-Q 2017-08-09
Q1 2017 519M +91.2M +21.3% Mar 17, 2017 10-K 2017-03-22
Q3 2016 429M Nov 7, 2016 10-Q 2016-11-10
Q2 2016 428M Aug 8, 2016 10-Q 2016-08-10
Q1 2016 427M May 9, 2016 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.